Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | BBI-825 |
Synonyms | |
Therapy Description |
BBI-825 inhibits ribonucleotide reductase, potentially leading to decreased tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): B082). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BBI-825 | BBI 825|BBI825 | BBI-825 inhibits ribonucleotide reductase, potentially leading to decreased tumor growth (Mol Cancer Ther (2023) 22 (12_Supplement): B082). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06299761 | Phase I | BBI-825 | Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications (STARMAP) | Recruiting | USA | 0 |